The complex genetic epidemiology of prostate cancer

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 1, 2004, Pages

  Schaid, Daniel J ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AROMATIC AMINE; AROMATIC HYDROCARBON; BRCA1 PROTEIN; BRCA2 PROTEIN; DIHYDROXYCOLECALCIFEROL; LYCOPENE; RIBONUCLEASE L; SCAVENGER RECEPTOR; SELENIUM; TESTOSTERONE; VITAMIN D; ZINC;

AGE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 8P; CHROMOSOME XQ; COLON CANCER; DEVELOPED COUNTRY; DIETARY INTAKE; ENVIRONMENTAL FACTOR; ETHNOLOGY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FAT INTAKE; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; LINKAGE ANALYSIS; MALE; MEAT; MOUSE; NEGRO; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REVIEW; RISK FACTOR; SEGREGATION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EPIDEMIOLOGIC STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 1842612064     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (187)

1. Hsing, A., Tsao, L. and Devesa, S. (2000) International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer, 85, 60-67.
2. Kolonel, L. (1997) Racial and geographic variations in prostate cancer and the effects of migration. In Fortner, J. and Sharp, P. (eds), Accomplishments in Cancer Research. Lippincot-Raven, Philadelphia, PA, pp. 221-230.
3. Shimizu, H., Ross, R., Bernstein, L., Yatani, R., Henderson, B. and Mack, T. (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer, 63, 963-966.
4. Parkin, D., Whelan, S., Ferlay, J., Raymond, L. and Young, J. (1997) Cancer Incidence in Five Continents, Vol. VII. International Agency for Research on Cancer, Lyon.
5. Jemel, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. and Thun, M. (2003) Cancer statistics, 2003. CA Cancer J. Clin., 53, 5-26.
6. Legler, J., Feuer, E., Potosky, A., Merrill, R. and Kramer, B. (1998) The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the USA. Cancer Causes Control, 9, 519-557.
7. Jacobsen, S., Katusic, S., Bergstrahl, E., Oesterling, J., Ohrt, D., Klee, G., Chute, C. and Lieber, M. (1995) Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA, 274, 1445-1449.
8. Ries, L., Eisner, M., Kosary, C., Hankey B.F., Miller B.A., Clegg L., Mariotto A., Fay M.P., Feuer E.J. and BK, E. (1999) SEER Cancer Statistics Review, 1973-1999. Available at: http://seer.cancer.gov/csr/1973-1999/. National Cancer Institute, Bethesda, MD.
9. Edwards, B., Howe, H., Ries, L., Thun MJ, Rosenberg HM, Yancik R, Wingo P.A., Jemal A. and EG, F. (2002) Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer, 94, 2766-2792.
10. DEVCAN probability of developing or dying of cancer software; http://srab.cancer.gov/devcan.
11. Hugosson, J., Aus, G., Becker, C., Carlsson, S., Eriksson, H., Lilja, H., Lodding, P. and Tibblin, G. (2000) Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int., 85, 1078-1084.
12. Pearson, J., Luderer, A., Metter, E., Partin, A., Chao, D., Fozard, J. and Carter, H. (1996) Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology, 48, 4-9.
13. Gann, P., Hennekens, C. and Stampfer, M. (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA, 273, 289-294.
14. Hayes, R.B., Liff, J.M., Pottern, L.M., Greenberg, R.S., Schoenberg, J.B., Schwartz, A.G., Swanson, G.M., Silverman, D.T., Brown, L.M., Hoover, R.N. et al. (1995) Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int. J. Cancer, 60, 361-364.
15. Whittemore, A.S., Wu, A.H., Kolonel, L.N., John, E.M., Gallagher, R.P., Howe, G.R., West, D.W., Teh, C.Z. and Stamey, T. (1995) Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am. J. Epidemiol., 141, 732-740.
16. Schuman, L.M., Mandel, J., Blackard, C., Bauer, H., Scarlett, J. and McHugh, R. (1977) Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep., 61, 181-186.
17. Cannon, L., Bishop, D., Skolnick, M., Hunt, S., Lyon, J. and Smart, C. (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv.. 1, 47-69.
18. Steinberg, G.D., Carter, B.S., Beaty, T.H., Childs, B. and Walsh, P.C. (1990) Family history and the risk of prostate cancer. Prostate, 17, 337-347.
19. Spitz, M., Currier, R., Fueger, J., Babaian, R. and Newell, G. (1991) Familial patterns of prostate cancer: A case-control analysis. J. Urol., 146, 1305-1307.
20. Keetch, D.W., Rice, J.P., Suarez, B.K. and Catalona, W.J. (1995) Familial aspects of prostate cancer: A case control study. J. Urol., 154, 2100-2102.
21. Isaacs, S., Kiemeney, L., Baffoe-Bonnie, A., Beaty, T. and Walsh, P. (1995) Risk of cancer in relatives of prostate cancer probands. J. Natl Cancer Inst., 87, 991-996.
22. Lesko, S.M., Rosenberg, L. and Shapiro, S. (1996) Family history and prostate cancer risk. Am. J. Epidemiol., 144, 1041-1047.
23. Ghadirian, P., Howe, G.R., Hislop, T. and Maisonneuve, P. (1997) Family history of prostate cancer; a mutli-center case-control study in Canada. Int. J. Cancer, 70, 679-681.
24. Glover, F., Coffey, D., Douglas, L., Russell, H., Cadigan, M., Tulloch, T., Wedderburn, K., Wan, R., Baker, T. and Walsh, P. (1998) Familial study of prostate cancer in Jamaica. Urology, 52, 441-443.
25. Bratt, O., Kristoffersson, U., Lundgren, R. and Olsson, H. (1999) Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur. J. Cancer, 35, 272-277.
26. Goldgar, D.E., Easton, D.F., Cannon-Albright, L.A. and Skolnick, M.H. (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl Cancer Inst., 86, 1600-1608.
27. Hemminki, K. and Czene, K. (2002) Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer, 95, 1346-1353.
28. Johns, L.E. and Houlston, R.S. (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int., 91, 789-794.
29. Cerhan, J., Parker, A., Putnam, S., Chiu, B.C.-H., Lynch, C., Cohen, M., Torner, J. and Cantor, K. (1999) Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol. Biomark. Prev., 8, 53-60.
30. Grönberg, H., Damber, L. and Damber, J. (1996) Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer, 77, 138-143.
31. Cunningham, G., Ashton, C., Annegers, J., Souchek, J., Klima, M. and Miles, B. (2003) Familial aggregation of prostate cancer in African-Americans and White Americans. Prostate, 56, 256-262.
32. Monroe, K.R., Yu, M.C., Kolonel, L.N., Coetzee, G.A., Wilkens, L.R., Ross, R.K. and Henderson, B.E. (1995) Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat. Med., 1, 827-829.
33. Narod, S., Dupont, A., Cusan, L., Diamond, P., Gomez, J., Suburu, R. and Labrie, F. (1995) The impact of family history on early detection of prostate cancer. Nat. Med., 1, 99-101.
34. Staples, M.P., Giles, G.G., English, D.R., McCredie, M.R., Severi, G., Cui, J.S. and Hopper, J.L. (2003) Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control, 14, 161-166.
35. Makinen, T., Tammela, T.L., Stenman, U.H., Maattanen, L., Rannikko, S., Aro, J., Juusela, H., Hakama, M. and Auvinen, A. (2002) Family history and prostate cancer screening with prostate-specific antigen. J. Clin. Oncol., 20, 2658-2663.
36. Stone, S.N., Hoffman, R.M., Tollestrup, K., Stidley, C.A., Witter, J.L. and Gilliland, F.D. (2003) Family history, Hispanic ethnicity, and prostate cancer risk. Ethn. Dis., 13, 233-239.
37. Carter, B.S., Beaty, T.H., Steinberg, G.D., Childs, B. and Walsh, P.C. (1992) Mendelian inheritance of familial prostate cancer. Proc. Natl Acad. Sci. USA, 89, 3367-3371.
38. Schaid, D., McDonnell, S., Blute, M. and Thibodeau, S. (1998) Evidence for autosomal dominant inheritance of prostate cancer. Am. J. Hum. Genet., 62, 1425-1438.
39. Verhage, B.A., Baffoe-Bonnie, A.B., Baglietto, L., Smith, D.S., Bailey-Wilson, J.E., Beaty, T.H., Catalona, W.J. and Kiemeney, L.A. (2001) Autosomal dominant inheritance of prostate cancer: A confirmatory study. Urology, 57, 97-101.
40. Valeri, A., Briollais, L., Azzouzi, R., Fournier, G., Mangin, P., Berthon, P., Cussenot, O. and Demenais, F. (2003) Segregation analysis of prostate cancer in France: Evidence for autosomal dominant inheritance and residual brother-brother dependence. Ann. Hum. Genet., 67, 125-137.
41. Grönberg, H., Damber, L., Damber, J.-E. and Iselius, L, (1997) Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am. J. Epidemiol., 146, 552-557.
42. Cui, J., Staples, M.P., Hopper, J.L., English, D.R., McCredie, M.R. and Giles, G.G. (2001) Segregation analyses of 1,476 population-based australian families affected by prostate cancer. Am. J. Hum. Genet., 68, 1207-1218.
43. Gong, G., Oakley-Girvan, I., Wu, A.H., Kolonel, L.N., John, E.M., West, D.W., Felberg, A., Gallagher, R.P. and Whittemore, A.S. (2002) Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control, 13, 471-482.
44. Conlon, E.M., Goode, E.L., Gibbs, M., Stanford, J.L., Badzioch, M., Janer, M., Kolb, S., Hood, L., Ostrander, E.A., Jarvik, G.P. et al. (2003) Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset. Int. J. Cancer, 105, 630-635.
45. Ahbom, A., Lichtenstein, P., Malmstrom, H., Feychting, M., Hemminki, K. and Pedersen, N. (1997) Cancer in twins: Genetic and nongenetic familial risk factors. J. Natl Cancer Inst., 89, 287-293.
46. Grönberg, H., Damber, L. and Damber, J.-E. (1994) Studies of genetic factors in prostate cancer in a twin population. J. Urol., 152, 1484-1489.
47. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finlandd. New Engl. J. Med., 343, 78-85.
48. Risch, N. (2001) The genetic epidemiology of cancer: interpreting familial and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomark. Prev., 10, 733-741.
49. Page, W.F., Braun, M.M., Partin, A.W., Caporaso, N. and Walsh, P. (1997) Heredity and prostate cancer: A study of World War II veteran twins. Prostate, 33, 140-145.
50. Carter, B., Bova, G., Beaty, T., Steinberg, G., Childs, B., Isaacs, W. and Walsh, P. (1993) Hereditary prostate cancer: Epidemiologic and clinical features. J. Urol., 150, 797-802.
51. Bratt, O. (2002) Hereditary prostate cancer: Clinical aspects. J. Urol., 168, 906-913.
52. Lopez-Otin, C. and Diamandis, E.P. (1998) Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features. Endocr. Rev., 19, 365-396.
53. Macklin, M. (1954) The genetic basis of human mammary cancer. Proceedings of Second National Cancer Conference. American Chemical Society, New York, pp. 1074-1087.
54. Thiessen, E. (1974) Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer, 34, 1102-1107.
55. Tulinius, H., Egilsson, V., Olafsdottir, G.H. and Sigvaldason, H. (1992) Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br. Med. J., 305, 855-857.
56. Arason, A., Barkardottir, R.B. and Egilsson, V. (1993) Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am. J. Hum. Genet., 52, 711-717.
57. Grabrick, D.M., Cerhan, J.R., Vierkant, R.A., Therneau, T.M., Cheville, J.C., Tindall, D.J. and Sellers, T.A. (2003) Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study. Cancer Detect. Prev., 27, 30-36.
58. Negri, E., Braga, C., La Vecchia, C., Franceschi, S. and Parazzini, F. (1997) Family history of cancer and risk of breast cancer. Int. J. Cancer, 72, 735-738.
59. Loman, N., Bladstrom, A., Johannsson, O., Borg, A. and Olsson, H. (2003) Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res., 5, R175-R186.
60. Anderson, D.E. and Badzioch, M.D. (1992) Breast cancer risks in relatives of male breast cancer patients. J. Natl Cancer Inst., 84, 1114-1117.
61. Valeri, A., Fournier, G., Morin, V., Morin, J.F., Drelon, E., Mangin, P., Teillac, P., Berthon, P. and Cussenot, O. (2000) Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int. J. Cancer, 86, 883-887.
62. Bratt, O., Kristoffersson, U., Lundgren, R. and Olsson, H. (1997) The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: A population-based cohort study. Eur. J. Cancer, 33, 2237-2240.
63. Damber, L., Grönberg, H. and Damber, J.E. (1998) Familial prostate cancer and possible associated malignancies: Nation-wide register cohort study in Sweden. Int. J. Cancer, 78, 293-297.
64. Kalish, L.A., McDougal, W.S. and McKinlay, J.B. (2000) Family history and the risk of prostate cancer. Urology, 56, 803-806.
65. Sellers, T.A., Potter, J.D., Rich, S.S., Drinkard, C.R., Bostick, R.M., Kushi, L.H., Zheng, W. and Folsom, A.R. (1994) Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J. Natl Cancer Inst., 86, 1860-1865.
66. Andrieu, N., Clavel, F., Auquier, A., Gairard, B., Bremond, A., Lansac, J., Piana, L., Flamant, R. and Renaud, R. (1991) Association between breast cancer and family malignancies. Eur. J. Cancer, 27, 244-248.
67. Rosenblatt, K.A., Thomas, D.B., McTiernan, A., Austin, M.A., Stalsberg, H., Stemhagen, A., Thompson, W.D., Curren, M.G., Satariano, W., Austin, D.F. et al. (1991) Breast cancer in men: Aspects of familial aggregation. J. Natl Cancer Inst., 83, 849-854.
68. Struewing, J.P., Hartge, P., Wacholder, S., Baker, S.M., Berlin, M., McAdams, M., Timmerman, M.M., Brody, L.C. and Tucker, M.A. (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl. J. Med., 336, 1401-1408.
69. Warner, E., Foulkes, W., Goodwin, P., Meschino, W., Blondal, J., Paterson, C., Ozcelik, H., Goss, P., Allingham-Hawkins, D., Hamel, N. et al. (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J. Natl Cancer Inst., 91, 1241-1247.
70. Giusti, R.M., Rutter, J.L., Duray, P.H., Freedman, L.S., Konichezky, M., Fisher-Fischbein, J., Greene, M.H., Maslansky, B., Fischbein, A., Gruber, S.B. et al. (2003) A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J. Med. Genet., 40, 787-792.
71. Hubert, A., Peretz, T., Manor, O., Kaduri, L., Wienberg, N., Lerer, I., Sagi, M. and Abeliovich, D. (1999) The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am. J. Hum. Genet., 65, 921-924.
72. Lehrer, S., Fodor, F., Stock, R.G., Stone, N.N., Eng, C., Song, H.K. and McGovern, M. (1998) Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Br. J. Cancer, 78, 771-773.
73. Nastiuk, K.L., Mansukhani, M., Terry, M.B., Kularatne, P., Rubin, M.A., Melamed, J., Gammon, M.D., Ittmann, M. and Krolewski, J.J. (1999) Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate, 40, 172-177.
74. Vazina, A., Baniel, J., Yaacobi, Y., Shtriker, A., Engelstein, D., Leibovitz, I., Zehavi, M., Sidi, A.A., Ramon, Y., Tischler, T. et al. (2000) The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Br. J. Cancer, 83, 463-466.
75. Edwards, S.M., Kote-Jarai, Z., Meitz, J., Hamoudi, R., Hope, Q., Osin, P., Jackson, R., Southgate, C., Singh, R., Falconer, A. et al. (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am. J. Hum. Genet., 72, 1-12.
76. The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J. Natl. Cancer Inst., 91, 1310-1316.
77. Sinclair, C.S., Berry, R., Schaid, D., Thibodeau, S.N. and Couch, F.J. (2000) BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res., 60, 1371-1375.
78. Gibbs, M., Stanford, J.L., McIndoe, R.A., Jarvik, G.P., Kolb, S., Goode, E.L., Chakrabarti, L., Schuster, E.F., Buckley, V.A., Miller, E.L. et al. (1999) Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am. J. Hum. Genet., 64, 776-787.
79. Lander, E. and Kruglyak, L. (1995) Genetic dissection of complex traits: Guidelines for interpreting and reporting results. Nat. Genet., 11, 241-247.
80. Witte, J.S., Elston, R.C. and Schork, N.J. (1996) Genetic dissection of complex traits. Nat. Genet., 12, 355-356; author reply 357-358.
81. Sawcer, S., Jones, H.B., Judge, D., Visser, F., Compston, A., Goodfellow, P.N. and Clayton, D. (1997) Empirical genomewide significance levels established by whole genome simulations. Genet. Epidemiol., 14, 223-229.
82. Simard, J., Dumont, M., Labuda, D., Sinnett, D., Meloche, C., El-Alfy, M., Berger, L., Lees, E., Labrie, F. and Tavtigian, S.V. (2003) Prostate cancer susceptibility genes: Lessons learned and challenges posed. Endocr. Relat. Cancer, 10, 225-259.
83. Smith, J.R., Freije, D., Carpten, J.D., Grönberg, H., Xu, J., Isaacs, S.D., Brownstein, M.J., Bova, G.S., Goo, H., Bujinovszky, P. et al. (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science, 274, 1371-1374.
84. Whittemore, A.S. and Halpern, J. (2001) Problems in the definition, interpretation, and evaluation of genetic heterogeneity. Am. J. Hum. Genet., 68, 457-465.
85. Xu, J., Zheng, S.L., Chang, B., Smith, J.R., Carpten, J.D., Stine, O.C., Isaacs, S.D., Wiley, K.E., Henning, L., Ewing, C. et al. (2001) Linkage of prostate cancer susceptibility loci to chromosome 1. Hum. Genet., 108, 335-345.
86. Grönberg, H., Xu, J., Smith, J.R., Carpten, J.D., Isaacs, S.D., Freije, D., Bova, G.S., Walsh, P.C., Collins, F.S., Trent, J.M. et al. (1997) Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res., 57, 4707-4709.
87. Cooney, K.A., McCarthy, J.D., Lange, E., Huang, L., Miesfeldt, S., Montie, J.E., Oesterling, J.E., Sandler, H.M. and Lange, K. (1997) Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. J. Natl Cancer Inst., 89, 955-959.
88. Hsieh, C.-L., Oakley-Girvan, I., Gallagher, R.P., Wu, A.H., Kolonel, L.N., Teh, C.Z., Halpern, J., West, D.W., Paffenberger, R.S. Jr and Whittemore, A.S. (1997) Re: Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. J. Natl Cancer Inst., 89, 1893-1894.
89. Neuhausen, S.L., Farnham, J.M., Kort, E., Tavtigian, S.V., Skolnick, M.H. and Cannon-Albright, L.A. (1999) Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees. Hum. Mol. Genet., 8, 2437-2442.
90. Goddard, K.A., Witte, J.S., Suarez, B.K., Catalona, W.J. and Olson, J.M. (2001) Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am. J. Hum. Genet., 68, 1197-1206.
91. Suarez, B.K., Lin, J., Burmester, J.K., Broman, K.W., Weber, J.L., Banerjee, T.K., Goddard, K.A.B., Witte, J.S., Elston, R.C. and Catalona, W.J. (2000) A genome screen of multiplex prostate cancer sibships. Am. J. Hum. Genet., 66, 933-944.
92. Grönberg, H., Isaacs, S., Smith, J., Carpten, J., Bova, G., Freije, D., Xu, J., Meyers, D., Collins, F., Trent, J. et al. (1997) Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA, 278, 1251-1255.
93. Goode, E.L., Stanford, J.L., Peters, M.A., Janer, M., Gibbs, M., Kolb, S., Badzioch, M., Hood, L., Ostrander, E.A. and Jarvik, G.P. (2001) Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci. J. Clin. Cancer Res., 7, 2739-2749.
94. Berthon, P., Valeri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wohr, G., Latil, A., Millasseau, P., Mellah, I., Cohen, N. et al. (1998) Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am. J. Hum. Genet., 62, 1416-1424.
95. Eeles, R.A., Durocher, F., Edwards, S., Teare, D., Badzioch, M., Hamoudi, R., Gill, S., Biggs, P., Dearnaley, D., Ardern-Jones, A. et al. (1998) Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am. J. Hum. Genet., 62, 653-658.
96. Goode, E.L., Stanford, J.L., Chakrabarti, L., Gibbs, M., Kolb, S., McIndoe, R.A., Buckley, V.A., Schuster, E.F., Neal, C.L., Miller, E.L. et al. (2000) Linkage analysis of 150 high-risk prostate cancer families at 1q24-25. Genet. Epidemiol., 18, 251-275.
97. Berry, R., Schaid, D.J., Smith, J.R., French, A.J., Schroeder, J.J., McDonnell, S.K., Peterson, B.J., Wang, Z.Y., Carpten, J.D., Roberts, S.G. et al. (2000) Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. Am. J Hum. Genet., 66, 539-546.
98. Xu, J. (2000) Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am. J. Hum. Genet., 66, 945-957.
99. Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., Faruque, M., Moses, T., Ewing, C., Gillanders, E. et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat. Genet., 30, 181-184.
100. Nelson, W.G., De Marzo, A.M. and Isaacs, W.B. (2003) Prostate cancer. New Engl. J. Med., 349, 366-381.
101. Rokman, A., Ikonen, T., Seppala, E.H., Nupponen, N., Autio, V., Mononen, N., Bailey-Wilson, J., Trent, J., Carpten, J., Matikainen, M.P. et al. (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am. J. Hum. Genet., 70, 1299-1304.
102. Chen, H., Griffin, A.R., Wu, Y.Q., Tomsho, L.P., Zuhlke, K.A., Lange, E.M., Gruber, S.B. and Cooney, K.A. (2003) RNASEL mutations in hereditary prostate cancer. J. Med. Genet., 40, e21.
103. Rennert, H., Bercovich, D., Hubert, A., Abeliovich, D., Rozovsky, U., Bar-Shira, A., Soloviov, S., Schreiber, L., Matzkin, H., Rennert, G. et al. (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am. J. Hum. Genet., 71, 981-984.
104. Casey, G., Neville, P.J., Plummer, S.J., Xiang, Y., Krumroy, L.M., Klein, E.A., Catalona, W.J., Nupponen, N., Carpten, J.D., Trent, J.M. et al. (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat. Genet., 32, 581-583.
105. Wang, L., McDonnell, S., Elkins, D., Slager, S., Christensen, E., Marks, A., Cunningham, J., Peterson, B., Jacobsen, S., Cerhan, J. et al. (2002) Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am. J. Hum. Genet., 71, 116-123.
106. Nakazato, H., Suzuki, K., Matsui, H., Ohtake, N., Nakata, S. and Yamanaka, H. (2003) Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br. J. Cancer, 89, 691-696.
107. Cancel-Tassin, G., Latil, A., Valeri, A., Mangin, P., Fournier, G., Gerthon, P. and Cussenot, O. (2001) PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Eur. J. Hum. Genet., 9, 135-142.
108. Suarez, B.K., Lin, J., Witte, J.S., Conti, D.V., Resnick, M.I., Klein, E.A., Burmester, J.K., Vaske, D.A., Banerjee, T.K. and Catalona, W.J. (2000) Replication linkage study for prostate cancer susceptibility genes. Prostate, 45, 106-114.
109. Gibbs, M., Stanford, J.L., Jarvik, G.P., Janer, M., Badzioch, M., Peters, M.A., Goode, E.L., Kolb, S., Chakrabarti, L., Shook, M. et al. (2000) A genomic scan of families with prostate cancer identifies multiple regions of interest. Am. J. Hum. Genet., 67, 100-109.
110. Gibbs, M., Chakrabarti, L., Stanford, J.L., Goode, E.L., Kolb, S., Schuster, E.F., Buckley, V.A., Shook, M., Hood, L., Jarvik, G.P. et al. (1999) Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am. J. Hum. Genet., 64, 1087-1095.
111. Whittemore, A.S., Lin, I.G., Oakley-Girvan, I., Gallagher, R.P., Halpern, J., Kolonel, L.N., Wu, A.H. and Hsieh, C.-L. (1999) No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. Am. J. Hum. Genet., 65, 254-256.
112. Maier, C., Rosch, K., Herkommer, K., Bochum, S., Cancel-Tassin, G., Cussenot, O., Haussler, J., Assum, G., Vogel, W. and Paiss, T. (2002) A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer. Eur. Urol., 42, 301-307.
113. Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., Ewing, C., Wilkens, E., Bujinovszky, P., Bova, G.S. et al. (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat. Genet., 20, 175-179.
114. Schleutker, J., Matikainen, M., Smith, J., Koivisto, P., Baffoe-Bonnie, A., Kainu, T., Gillanders, E., Sankila, R., Pukkala, E., Carpten, J. et al. (2000) A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease. Clin. Cancer Res., 6, 4810-4815.
115. Lange, E.M., Chen, H., Brierley, K., Perrone, E.E., Bock, C.H., Gillanders, E., Ray, M.E. and Cooney, K.A. (1999) Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX. Clin. Cancer Res., 5, 4013-4020.
116. Hsieh, C.-L., Oakley-Girvan, I., Balise, R.R., Halpern, J., Gallagher, R.P., Wu, A.H., Kolonel, L.N., O'Brien, L.E., Lin, I.G., Van Den Berg, D.J. et al. (2001) A genome screen of families with multiple cases of prostate cancer: Evidence of genetic heterogeneity. Am. J. Hum. Genet., 69, 148-158.
117. Bochum, S., Paiss, T., Vogel, W., Herkommer, K., Hautmann, R. and Haeussler, J. (2002) Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families. Prostate, 52, 12-19.
118. Peters, M.A., Jarvik, G.P., Janer, M., Chakrabarti, L., Kolb, S., Goode, E.L., Gibbs, M., DuBois, C.C., Schuster, E.F., Hood, L. et al. (2001) Genetic linkage analysis of prostate cancer families to Xq27-28. Hum. Hered., 51, 107-113.
119. Janer, M., Friedrichsen, D.M., Stanford, J.L., Badzioch, M.D., Kolb, S., Deutsch, K., Peters, M.A., Goode, E.L., Welti, R., DeFrance, H.B. et al. (2003) Genomic scan of 254 hereditary prostate cancer families. Prostate, 57, 309-319.
120. Badzioch, M., Eeles, R., Lebalanc, G., Foulkes, W.D., Giles, G., Edwards, S., Goldgar, D., Hopper, J.L., Bishop, D.T., Moller, P. et al. (2000) Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators. J. Med. Genet., 37, 947-949.
121. Berry, R., Schroeder, J., French, A., McDonnell, S., Peterson, B., Cunningham, J., Thibodeau, S. and Schaid, D. (2000) Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am. J. Hum. Genet., 67, 82-91.
122. Zheng, S.L., Xu, J., Isaacs, S.D., Wiley, K., Chang, B., Bleecker, E.R., Walsh, P.C., Trent, J.M., Meyers, D.A. and Isaacs, W.B. (2001) Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families. Hum. Genet., 108, 430-435.
123. Bock, C.H., Cunningham, J.M., McDonnell, S.K., Schaid, D.J., Peterson, B.J., Pavlic, R.J., Schroeder, J.J., Klein, J., French, A.J., Marks, A. et al. (2001) Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am. J. Hum. Genet., 68, 795-801.
124. Cancel-Tassin, G., Latil, A., Valeri, A., Guillaume, E., Mangin, P., Fournier, G., Berthon, P. and Cussenot, O. (2001) No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer. Int. J. Cancer, 93, 455-456.
125. Bar-Shira, A., Pinthus, J.H., Rozovsky, U., Goldstein, M., Sellers, W.R., Yaron, Y., Eshhar, Z. and Orr-Urtreger, A. (2002) Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res., 62, 6803-6807.
126. Xu, J., Zheng, S.L., Hawkins, G.A., Faith, D.A., Kelly, B., Isaacs, S.D., Wiley, K.E., Chang, B., Ewing, C.M., Bujinovszky, P. et al. (2001) Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am. J. Hum. Genet., 69, 341-350.
127. Wiklund, F., Jonsson, B.A., Goransson, I., Bergh, A. and Grönberg, H. (2003) Linkage analysis of prostate cancer susceptibility: Confirmation of linkage at 8p22-23. Hum. Genet., 112, 414-418.
128. Xu, J., Zheng, S.L., Komiya, A., Mychaleckyj, J.C., Isaacs, S.D., Hu, J.J., Sterling, D., Lange, E.M., Hawkins, G.A., Turner, A. et al. (2002) Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat. Genet., 32, 321-325.
129. Xu, J., Zheng, S.L., Komiya, A., Mychaleckyj, J.C., Isaacs, S.D., Chang, B., Turner, A., Ewing, C.M., Wiley, K.E., Hawkins, G.A. et al. (2003) Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am. J. Hum. Genet., 72, 208-212.
130. Wang, L., McDonnell, S.K., Cunningham, J.M., Hebbring, S., Jacobsen, S.J., Cerhan, J.R., Slager, S.L., Blute, M.L., Schaid, D.J. and Thibodeau, S.N. (2003) No association of germline alteration of MSR1 with prostate cancer risk. Nat. Genet., 35, 128-129.
131. Seppala, E.H., Ikonen, T., Autio, V., Rokman, A., Mononen, N., Matikainen, M.P., Tammela, T.L. and Schleutker, J. (2003) Germ-line alterations in MSR1 gene and prostate cancer risk. Clin. Cancer Res., 9, 5252-5256.
132. Tavtigian, S., Simard, J., Teng, D., Abtin, V., Baumgard, M., Beck, A., Camp, N., Carillo, A., Chen, Y., Dayananth, P. et al. (2001) A strong candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet., 27, 172-180.
133. Rebbeck, T.R., Walker, A.H., Zeigler-Johnson, C., Weisburg, S., Martin, A.M., Nathanson, K.L., Wein, A.J. and Malkowicz, S.B. (2000) Association of HPC2/ELAC2 Genotypes and Prostate Cancer. Am. J. Hum. Genet., 67, 1014-1019.
134. Xu, J., Zheng, S.L., Carpten, J.D., Nupponen, N.N., Robbins, C.M., Mestre, J., Moses, T.Y., Faith, D.A., Kelly, B.D., Isaacs, S.D. et al. (2001) Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am. J. Hum. Genet., 68, 901-911.
135. Rokman, A., Ikonen, T., Mononen, N., Autio, V., Matikainen, M.P., Koivisto, P.A., Tammela, T.L., Kallioniemi, O.P. and Schleutker, J. (2001) ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res., 61, 6038-6041.
136. Camp, N.J. and Tavtigian, S.V. (2002) Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am. J. Hum. Genet., 71, 1475-1478.
137. Suarez, B.K., Gerhard, D.S., Lin, J., Haberer, B., Nguyen, L., Kesterson, N.K. and Catalona, W.J. (2001) Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res., 61, 4982-4984.
138. Vesprini, D., Nam, R.K., Trachtenberg, J., Jewett, M.A., Tavtigian, S.V., Emami, M., Ho, M., Toi, A. and Narod, S.A. (2001) HPC2 variants and screen-detected prostate cancer. Am. J. Hum. Genet., 68, 912-917.
139. Wang, L., McDonnell, S.K., Elkins, D.A., Slager, S.L., Christensen, E., Marks, A.F., Cunningham, J.M., Peterson, B.J., Jacobsen, S.J., Cerhan, J.R. et al. (2001) Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res., 61, 6494-6499.
140. Severi, G., Giles, G.G., Southey, M.C., Tesoriero, A., Tilley, W., Neufing, P., Morris, H., English, D.R., McCredie, M.R., Boyle, P. et al. (2003) ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J. Natl Cancer Inst., 95, 818-824.
141. Stanford J.L., Sabacan, L.P., Noonan, E.A., Iwasaki, L., Shu, J., Feng, Z. and Ostrander, E.A. (2003) Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer Epidemiol. Biomarkers Prev., 12, 876-881.
142. Adler, D., Kanji, N., Trpkov, K., Fick, G. and Hughes, R.M. (2003) HPC2/ELAC2 gene variants associated with incident prostate cancer. J. Hum. Genet., 48, 634-638.
143. Meitz, J.C., Edwards, S.M., Easton, D.F., Murkin, A., Ardern-Jones, A., Jackson, R.A., Williams, S., Dearnaley, D.P., Stratton, M.R., Houlston, R.S. et al. (2002) HPC2/ELAC2 polymorphisms and prostate cancer risk: Analysis by age of onset of disease. Br. J. Cancer, 87, 905-908.
144. Shea, P.R., Ferrell, R.E., Patrick, A.L., Kuller, L.H. and Bunker, C.H. (2002) ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. Hum. Genet., 111, 398-400.
145. Fujiwara, H., Emi, M., Nagai, H., Nishimura, T., Konishi, N., Kubota, Y., Ichikawa, T., Takahashi, S., Shuin, T., Habuchi, T. et al. (2002) Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. J. Hum. Genet., 47, 641-648.
146. Takahashi, H., Lu, W., Watanabe, M., Katoh, T., Furusato, M., Tsukino, H., Nakao, H., Sudo, A., Suzuki, H., Akakura, K. et al. (2003) Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. Int. J. Cancer, 107, 224-228.
147. Suzuki, K., Ohtake, N., Nakata, S., Takei, T., Matsui, H., Ono, Y., Nakazato, H., Hasumi, M., Koike, H., Ito, K. et al. (2002) Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population. Anticancer Res., 22, 3507-3511.
148. Easton, D.F., Schaid, D.J., Whittemore, A.S. and Isaacs, W.J. (2003) Where are the prostate cancer genes? - A summary of eight genome wide searches. Prostate, 57, 261-269.
149. Witte, J., Goddard, K., Conti, D., Elston, R., Lin, J., Suarez, B., Broman, K., Burmester, J., Weber, J. and Catalona, W. (2000) Genomewide scan for prostate cancer-aggressiveness loci. Am. J. Hum. Genet., 67, 92-99.
150. Neville, P.J., Conti, D.V., Paris, P.L., Levin, H., Catalona, W.J., Suarez, B.K., Witte, J.S. and Casey, G. (2002) Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia, 4, 424-431.
151. Neville, P.J., Conti, D.V., Krumroy, L.M., Catalona, W.J., Suarez, B.K., Witte, J.S. and Casey, G. (2003) Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer, 36, 332-339.
152. Slager, S., Schaid, D., Cunningham, J., McDonnell, S., Marks, A., Peterson, B., Hebbring, S., Anderson, S., French, A. and Thibodeau, S. (2003) Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am. J. Hum. Genet., 72, 759-762.
153. Witte, J.S., Suarez, B.K., Thiel, B., Lin, J., Yu, A., Banerjee, T.K., Burmester, J.K., Casey, G. and Catalona, W.J. (2003) Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate, 57, 298-308.
154. Paiss, T., Worner, S., Kurtz, F., Haeussler, J., Hautmann, R.E., Gschwend, J.E., Herkommer, K. and Vogel, W. (2003) Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families. Eur. J. Hum. Genet., 11, 17-22.
155. Schaid, D., Olson, J., Gauderman, W. and Elston, R. (2003) Regression models for linkage: Issues of traits, covariates, heterogeneity, and interaction. Hum. Hered., 55, 86-96.
156. Ross, R.K., Pike, M.C., Coetzee, G.A., Reichardt, J.K., Yu, M.C., Feigelson, H., Stanczyk, F.Z., Kolonel, L.N. and Henderson, B.E. (1998) Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility. Cancer Res., 58, 4497-4504.
157. Coughlin, S.S. and Hall, I.J. (2002) A review of genetic polymorphisms and prostate cancer risk. Ann. Epidemiol., 12, 182-196.
158. Ntais, C., Polycarpou, A. and Ioannidis, J.P. (2003) SRD5A2 gene polymorphisms and the risk of prostate cancer: A meta-analysis. Cancer Epidemiol. Biomarkers Prev., 12, 618-624.
159. Ntais, C., Polycarpou, A. and Ioannidis, J.P. (2003) Association of the CYP17 gene polymorphism with the risk of prostate cancer: A meta-analysis. Cancer Epidemiol. Biomarkers Prev., 12, 120-126.
160. Chang, B.L., Zheng, S.L., Hawkins, G.A., Isaacs, S.D., Wiley, K.E., Turner, A., Carpten, J.D., Bleecker, E.R., Walsh, P.C., Trent, J.M. et al. (2002) Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility Cancer Res., 62, 1784-1789.
161. Rebbeck, T.R. (2002) Inherited genotype and prostate cancer outcomes. Cancer Epidemiol. Biomarkers Prev., 11, 945-952.
162. Platz, E. and Helzlsouer, K. (2001) Selenium, zinc, and prostate cancer. Epidemiol. Rev., 23, 93-101.
163. Kolonel, L. (2001) Fat, meat, and prostate cancer. Epidemiol. Rev., 23, 72-81.
164. Chan, J. and Giovannucci, E. (2001) Vegetables, fruits, associated nutrients, and the risk of prostate cancer. Epidemiol. Rev., 23, 82-85.
165. Gann, P., Ma, J., Giovannucci, E., Willett, W., Sacks, F., Hennekens, C. and Stampfer, M. (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospecitve analysis. Cancer Res., 59, 1225-1230.
166. Heinonen, O., Albanes, D., Virtamo, J., Taylor, P., Huttunen, J., Hartman, A., Haapakoski, J., Malila, N., Rautalahti, M., Ripatti, S. et al. (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial. J. Natl Cancer Inst., 90, 440-446.
167. Clark, L., Combs, G.J., Turnbull, B., Slate, E., Chalker, D., Chow, J., Davis, L., Glover, R., Graham, G., Gross, E. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-1963.
168. Clark, L., Dalkin, B., Kongrad, A., Combs, G.J., Turnbull, B., Slate, E., Witherington, R., Herlong, J., Janosko, E., Carpenter, D. et al. (1998) Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br. J. Urol., 81, 730-734.
169. Chan, J. and Giovannucci, E. (2001) Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol. Rev., 23, 87-92.
170. Boyle, P., Severi, G. and Giles, G.G. (2003) The epidemiology of prostate cancer. Urol. Clin. N. Am., 30, 209-217.
171. Grönberg, H. (2003) Prostate cancer epidemiology. Lancet, 361, 859-864.
172. Parent, M.-E. and Siemiatycki, J. (2001) Occupation and prostate cancer. Epidemiol. Rev., 23, 138-143.
173. Powell, I.J., Carpten, J., Dunston, G., Kittles, R., Bennett, J., Hoke, G., Pettaway, C., Weinrich, S., Vijayakumar, S., Ahaghotu, C.A. et al. (2001) African-American heredity prostate cancer study: A model for genetic research. J. Natl Med. Assoc., 93, 120-123.
174. Schaid, D.J., Buetow, K., Weeks, D.E., Wijsman, E., Guo, S.W., Ott, J. and Dahl, C. (1999) Discovery of cancer susceptibility genes: Study designs, analytic approaches, and trends in technology. J. Natl Cancer Inst. Monogr, 1-16.
175. Sobel, E., Papp, J.C. and Lange, K. (2002) Detection and integration of genotyping errors in statistical genetics. Am. J. Hum. Genet., 70, 496-508.
176. Suarez, B.K., Hampe, C.L. and VanEedewegh, P. (1994) Problems of replicating linkage claims in psychiatry. In Gershon, E. and Cloninger, C. (eds), Genetic Approaches to Mental Disorders. American Psychopathological Association Series, Washington, DC, pp. 23-46.
177. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science, 273, 1516-1517.
178. Tabor, H., Risch, N. and Myers, R. (2002) Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat. Rev. Genet., 3, 1-7.
179. Gibbs, R.A., Belmont, J.W., Hardenbol, P., Willis, T.D., Yu, F., Yang, H., Ch'ang, L.Y., Huang, W., Liu, B., Shen, Y. et al. (2003) The International HapMap Project. Nature, 426, 789-796.
180. Conti, D.V., Cortessis, V., Molitor, J. and Thomas, D.C. (2003) Bayesian modeling of complex metabolic pathways. Hum. Hered., 56, 83-93.
181. Lan, H., Stoehr, J.P., Nadler, S.T., Schueler, K.L., Yandell, B.S. and Attie, A.D. (2003) Dimension reduction for mapping mRNA abundance as quantitative traits. Genetics, 164, 1607-1614.
182. Cunningham, J.M., McDonnell, S.K., Marks, A., Hebbring, S., Anderson, S.A., Peterson, B.J., Slager, S., French, A., Blute, M.L., Schaid, D.J. et al. (2003) Genome linkage screen for prostate cancer susceptibility loci: Results from the Mayo Clinic Familial Prostate Cancer Study. Prostate, 57, 335-346.
183. Edwards, S., Meitz, J., Eles, R., Evans, C., Easton, D., Hopper, J., Giles, G., Foulkes, W.D., Narod, S., Simard, J. et al. (2003) Results of a genomewide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate, 57, 270-279.
184. Lange, E.M., Gillanders, E.M., Davis, C.C., Brown, W.M., Campbell, J.K., Jones, M., Gildea, D., Riedesel, E., Albertus, J., Freas-Lutz, D. et al. (2003) Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate, 57, 326-334.
185. Schleutker, J., Baffoe-Bonnie, A.B., Gillanders, E., Kainu, T., Jones, M.P., Freas-Lutz, D., Markey, C., Gildea, D., Riedesel, E., Albertus, J. et al. (2003) Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate, 57, 280-289.
186. Wiklund, F., Gillanders, E.M., Albertus, J.A., Bergh, A., Damber, J.E., Emanuelsson, M., Freas-Lutz, D.E., Gildea, D.E., Goransson, I., Jones, M.S. et al. (2003) Genome-wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate, 57, 290-297.
187. Xu, J., Gillanders, E.M., Isaacs, S.D., Chang, B.L., Wiley, K.E., Zheng, S.L., Jones, M., Gildea, D., Riedesel, E., Albertus, J. et al. (2003) Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate, 57, 320-325.